|Medtronic Announces the Global Launch of the CD Horizon® Solera® Voyager (TM) Spinal System|
DUBLIN - July 8, 2015 - Medtronic plc (NYSE: MDT) today announced the launch of the CD HORIZON® SOLERA® VOYAGER(TM) Spinal System for Minimally Invasive Spine procedures. Available today in countries around the world, the CD HORIZON® SOLERA® VOYAGER(TM) System expands upon the transforaminal lumbar interbody fusion (TLIF) procedure by offering multiple, minimally invasive rod insertion options and enabling a seamless 3D-navigated surgical experience. The announcement was made during the 22nd annual international Meeting on Advanced Spine Techniques (IMAST) in Kuala Lumpur, Malaysia.
With the CD HORIZON® SOLERA® VOYAGER(TM) System, surgeons have the flexibility to use either a percutaneous or Wiltse minimally invasive approach for rod insertion depending upon their preference. The system also features a low-profile, extended-tab screw with inner threading, which eases rod insertion and facilitates rod reduction. In addition, the system is part of Medtronic's Surgical Synergy(TM) Spinal Platform - the most integrated portfolio of navigated surgical technologies - which seeks to minimize the operating room from interruption and constraints and gives surgeons the freedom to focus wholly on their patients.
"Medtronic is known for our life-changing innovations and groundbreaking technologies. That legacy - along with our broad portfolio and collaborative partnerships - enables us to truly make an impact on patient care," said Doug King, president of the Spinal business and senior vice president of Medtronic. This system represents our commitment to take minimally invasive techniques and 3D-navigated surgery even further and develop solutions with clinical and economic value."
Medtronic's Surgical Synergy(TM) Spinal Platform
About Medtronic Spinal
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.